دورية أكاديمية
The Role of Micronutrient Supplementation in the Management of Hashimoto's Thyroiditis: A Review of Current Evidence and Potential Mechanisms of Action
| العنوان: | The Role of Micronutrient Supplementation in the Management of Hashimoto's Thyroiditis: A Review of Current Evidence and Potential Mechanisms of Action |
|---|---|
| المؤلفون: | Sara Michalska, Rafał Makuch, Kamil Gała, Paweł Lenard, Adam Kucharski, Konrad Pilarski, Martyna Dewicka, Alicja Maria Wawrzyniak, Alicja Chrościcka, Andrzej Czajka |
| المصدر: | Quality in Sport, Vol 20 (2024) |
| بيانات النشر: | Nicolaus Copernicus University in Toruń, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Sports LCC:Sports medicine |
| مصطلحات موضوعية: | Hashimoto's thyroiditis, Hashimoto’s disease, autoimmune thyroid disease, Sports, GV557-1198.995, Sports medicine, RC1200-1245 |
| الوصف: | Introduction and objective: Hashimoto's thyroiditis (HT), the most prevalent autoimmune disorder and a primary cause of hypothyroidism globally, leads to thyroid gland damage through lymphocyte infiltration. Pharmacological treatment of HT involves the use of levothyroxine, which in most cases must be taken for life. However, supplementation with micronutrients is often overlooked. Several studies have examined the impact of substances such as selenium, zinc, vitamin B12, and vitamin D on the course of Hashimoto's disease. Review methods: Review and summary of research studies available in open-source format on Google Scholar, PubMed. Abbreviated description of the state of knowledge: Supplementation with selenium, zinc, vitamin D, and B12 shows potential benefits for patients with Hashimoto's disease. Summary: Regular monitoring and tailored supplementation of selenium, zinc, vitamin D, and vitamin B12 can enhance overall health and disease management. Therefore, it is worth considering the supplementation of these micronutrients in the daily routine of patients with Hashimoto's thyroiditis. However, it should be noted that these supplements do not constitute a treatment for Hashimoto's disease and their effect cannot replace the intake of levothyroxine. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2450-3118 |
| Relation: | https://apcz.umk.pl/QS/article/view/53265; https://doaj.org/toc/2450-3118 |
| DOI: | 10.12775/QS.2024.20.53265 |
| URL الوصول: | https://doaj.org/article/f53bfeac4edd42d98816a6a9b3d37f03 |
| رقم الأكسشن: | edsdoj.f53bfeac4edd42d98816a6a9b3d37f03 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 24503118 |
|---|---|
| DOI: | 10.12775/QS.2024.20.53265 |